Cargando…
Activated PI3Kδ syndrome – reviewing challenges in diagnosis and treatment
Activated PI3Kδ syndrome (APDS) is a rare inborn error of immunity (IEI) characterized primarily by frequent infections, lymphoproliferation and autoimmunity. Since its initial description in 2013, APDS has become part of the growing group of nearly 500 IEIs affecting various components of the immun...
Autores principales: | Vanselow, Sven, Wahn, Volker, Schuetz, Catharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432830/ https://www.ncbi.nlm.nih.gov/pubmed/37600808 http://dx.doi.org/10.3389/fimmu.2023.1208567 |
Ejemplares similares
-
The Treatment of Activated PI3Kδ Syndrome
por: Coulter, Tanya I., et al.
Publicado: (2018) -
Future Directions in the Diagnosis and Treatment of APDS and IEI: a Survey of German IEI Centers
por: Vanselow, Sven, et al.
Publicado: (2023) -
Epstein–Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency
por: Carpier, Jean-Marie, et al.
Publicado: (2018) -
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome
por: Rao, V. Koneti, et al.
Publicado: (2023) -
Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome
por: Asano, Takaki, et al.
Publicado: (2018)